第一章 緒 論
1. 宋繼謁主編. 病理學. 北京：科學出版社，1999，1-5
2. 楊光華主編. 病理學. 第五版. 北京：人民衛(wèi)生出版社，2001，1-6
3. Underwood JCE. Generaland Systematic Pathology. 3rd ed, London:Churchill livingstone,2000，3-11
第二章 細胞和組織的適應和損傷
1. Cotran RS, Kumar V, Collins T. RobbinsPathologic Basis of Disease. 6th ed .Philadelphia: W.B.Saunders Company,1999; P1-48
2. Majno G,
3. Dervan P, HarrisonM. Mind Maps in Pathology. London: ChurchillLivingstone, 2002; P1-6
4. Brown E. Basic Concepts in Pathology. The McGraw-Hill Companies, Inc. 1998;P3-87
5. Underwood JCE. General and Systematic Pathology.2ed ed. Beijing:Science Press, 1999. 112-119
第三章 損傷的修復
1． Werb Z. ECM and cell surface proteolysis regulating cellularecology. Cell, 1997,91:439-442
2．Solo T, Malkela M, Kylmaniemi M, et al. Expressionof matrix metalloproteinase-2 and -2 during early human wound healing. Lab Invest, 1994, 70: 176-182
3． Martinez-Hernandez A. Repair, regeneration, andfibrosis. In: Rubin E and Farber JL, eds. Pathology. 3rd ed. Philadelphia:Lippincott-Raven, 1998. 76-103
4． Martin P. Wound healing-aiming for perfect skinregeneration. Science, 1997, 276: 75-81
5．Nicholas NN, Peter JP, Richard LG. Basic fibroblast growth factormediates angiogenic activity in early surgical wounds. Surgery, 1996, 119:457-465
6． Folkman J. Tumor angiogenesis. In:Mendelsohn J, et al. eds. Themolecular basic of cancer. Philadelphi-a: WB Saunders, 1995. 206-232
7． Turner AJ, Tanzawa K. Mammalian membrane metallopeptidases: NEP,ECE, KELL, and PEX. FASEB J, 1997, 11: 355-364
8． Goetzl EJ, Banda MJ, Leppert D. Matrix metalloprotenases inimmunity. J Immunol, 1996, 156: 1-4
第四章 局部血液及體液循環(huán)障礙
1． Cotran RS, Kumar V, Collins T. Robbins PathologicBases of Disease. 6th ed. Philadelphia:WB Saunders. 1999. 79-102
2．Reddick RL, Bellinger DA: Hemostasis and thrombosis. In: Anderson’sPathology. 10th ed. St Louis:Mos-by, 1996. 472-483.
3． Mitchell RN and Cotran RS. Hemodynamicdisorders, thrombosis, and shock. In：Cotran RS, Kumar V, Collins T, eds. PathologicBasis of Diseases. 6th ed. Philadephia: W.B.Saunders, 1999. 113-138.
第五章 炎 癥
1. Cotran RS, Kumar V, Collins T. Robbins PathologicBases of Disease. 6th ed. Philadelphia:WB Saunders. 2002, 33
2. Robert B. Clark:Therole of PPARs in inflammation and immunity. Journal of Leuko Biol. 2002;71:388-400
3. Hommes DW, Peppelenbosch MP, Deventer SJ:Mitogen activated protein (MAP) kinase: Signal transductionpathways and novel anti-inflammatory targets. Gut, 2003;52:144
4. Dray A:Inflammatorymediators of pain. Br J Anaeth, 1997,75:125
5.Richard N, Mitchell RS, Contran RS. Acute and chronicinflammation. In: Kumar V, Contran RS, Robbins SL.Basic Pathology. 6th ed. Philadephia: W.B. Saunders, 1997. 25-47
6 Cotran RS, Mayadas TN:Endothelial adhesion molecules in health and disease. Pathol Biol, . 1998, 46: 164-172
第六章 腫 瘤
1.曾益新主編. 腫瘤學,人民衛(wèi)生出版社. 1999, 11.11, P10
2.劉彤華主編，診斷病理學，北京，人民衛(wèi)生出版社，2000，p7
3.李連弟，饒克勤，張思維等，中國12市縣1993年-1997年腫瘤發(fā)病和死亡登記資料統(tǒng)計分析，中國腫瘤，2002,11(9):497
第七章 心血管系統(tǒng)疾病
1．動脈粥樣硬化病理普查協(xié)作組. 7, 159例冠狀動脈和2,044例主動脈粥樣硬化病理普查總結.中華病理學雜志，1983，12：81-85
2 Ross R. The pathogenesis of atherosclerosis, a perspective for the 1990s,Nature, 1993, 362: 801
3． Kaiser TM. Endothelial cell functions. Relationship to artherogenesis. Basic Res Cardiol, 1999, 94:295-314
4． Xu XP, Meisel SR, Ong JM, et al. Oxdized low-density lipoptroteinregulates matrix metalloproteinase-9 and its tissue inhibitor in human moncyte-derivedmacrophages. Circulation, 1999, 99: 993-998.
5． 1999年世界衛(wèi)生組織/國際高血壓聯(lián)盟關于高血壓治療指南. 高血壓雜志，1999， 7：97-100
6.饒栩栩，黃震東，岑潤超，等. 我國風濕性心臟病的流行現(xiàn)狀.國家“八五”風濕熱課題風濕性心臟病調查報告. 中國心血管病雜志，1998，26：98-100
7.1999世界衛(wèi)生組織/國際高血壓聯(lián)盟關于高血壓指南，高血壓雜志，1999，7：97。
第八章 呼吸系統(tǒng)疾病
1.Budiani DR, Hutahaean S,Haryana SM,et al.Interleukin-10 levels in Epstein-barr virus-associated nasopharyngealcarcinoma. J Microbiol Immunol Infect 2002;35(4):265~268.
2. Yucesoy B,VallyathanV,Landsittel DP, et al. Cytokine polymorphisms in silicosis and otherpneumoconiosis. Mol cell Biochem 2002:234-235(1-2):219-224.
3. Huang SH,HubbsAF,Stanley CF,et al. Immunoglobulin responses to experimental silicosis.Toxicol Sci 2001 Jan;59(1):108-17.
4. Minematsu N, Nakamura H, Tateno H, etal. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.Biochem Biophys Res Commun 2001 Nov 23;289(1):116-9.
5．全國肺心病病理協(xié)作組. 662例慢性肺源性心臟病尸檢病理分析. 中國病理學雜志，1990，19：22-25
6．Wagner GR. Asbestosis and silicosis. Lancet, 1997. 349: 1311-1315
7．Pathamanathan R, Prasad U, Chandrika G, et al. Undifferentiated andnonkeratinizing squamous cell carcinoma of the nasophaynx. Am J Pathol, 1995,146: 1355-1367
第九章 消化系統(tǒng)疾病
1. Whitehead R. Gastrointestinal andOesophageal Pathology.2thed. ChurchillLivingstone.Newyork.1995.
2. 陳紫榕主編. 病毒性肝炎.北京：人民衛(wèi)生出版社，2002.45－110
3. 羅賽（Rosai,J)著，回允中譯. 阿克曼外科病理學. 沈陽：遼寧教育出版社，1999.857－969
4. 孫保存. 胃腸道. 見譚郁彬、張乃鑫主編. 外科診斷病理學. 天津：天津科技出版社，2000.462-474
5. 來茂德. 大腸癌發(fā)生的分子機理. 實用腫瘤雜志，2000，15：73-78
9．Ishak KG. Pathologic features of chronic hepatitis. Am J Clin Pathol, 2000, 113: 40-55
6. 12．Schiff ER, Medina MD, Kahn RS. New Perspectives in the diagnosis of hepatitis C. Sen liverDisease, 1999, 19（suppl)：3-6
第十章 淋巴造血系統(tǒng)疾病
1． Harris NL, Jaffe ES, Diebold J, et al. TheWorld Health Organization Classification of neoplastic diseases of thehaematopoitic and lymphoid tissues: report of the Clinical Advisory CommitteeMeeting, Airlie House, Virginia, November 1997. Histopathology,2000,36:69-87.
2.Harris NL, Jaffe ES, Stein H, et al. A revised European-American classificationof lymphoid neoplasms: a proposal from the international lymphoma study group.Blood, 1994, 84:1361-1392.
3. Harris NL, Jaffe ES, Biebol52667788.cnd J, et al.The World Health Organization Classification of neoplastic disease of thehaematopoitic and lymphoid tissues: report of the Clinical Advisory CommitteeMeeting, Airlie House, Virginia, November 1997. Histopathology,2000, 36: 69-87
4. 劉復生. 惡性淋巴瘤的流行病學. 見：朱梅剛和周志韶主編. 淋巴組織增生性疾病病理學，第七章. 廣州：廣東高等教育出版社，1994. 77-87
5．全國何杰金氏病研究協(xié)作組. 1029例何杰金氏病組織病理回顧研究.中華病理學雜志，1991，20：263～26
第十一章 泌尿系統(tǒng)疾病
1. Churg J，Bernstein J， Glassock RJ： Renal Disease， Classification and atlas of glomerular disease， 2nd ed. Igaku-shoin Tokyo， 1995.
2. Heptinstall RH： Pathology of the kidney， 4th ed. Little Brown， Boston， 1992.
3. 鄒萬忠主編.腎臟病理與臨床. 長沙： 湖南科學技術出版社， 1993
第十二章 生殖系統(tǒng)和乳腺疾病
1. 陳忠年，杜心谷，劉伯寧主編．婦產科病理學．上海：上海醫(yī)科大學出版社，1996.
2． Ekman P, et al. Enviromental and genetic factors: a possible likewith prostate52667788.cn/sanji/ cancer. Br J Urol, 1997, 79（suppl 2)：35-4
3． Bertwistle D, Ashworth A. Functions of the BRCA1 and BRCA2 genes. Curr Opin Genet Dev, 1998. 8: 14-20.
4．Christopher DM Fletcher. Diagnostic Histopathologyof Tumors. USA,2001
10．鄭香玲. HPV感染與尖銳濕疣及癌變等相關性分析.臨床與實驗病理學雜志,1999,15(1):88
第十三章 內分泌系統(tǒng)疾病
1.武忠弼、楊光華主編.中華外科病理學（中卷). 北京：人民衛(wèi)生出版社，2002,1726-1855.
2.Dayan CM, Daniels GH. Chronic autoimmune thyroiditis.N Eng J Med,
1996,335:99-107.
3.譚郁彬、張乃鑫.外科診斷病理學.第一版.天津：天津科學技術出版社,
2000,537-541.832-893
4．劉新民. 實用內分泌學. 第二版，北京：人民軍醫(yī)出版社，1997，357-487
5.譚郁彬，張乃鑫. 外科診斷病理學. 天津：天津科學技術出版社，2000，537-541，832-893
6.孫遜，孟祥偉．618例甲狀腺腺瘤與結節(jié)性甲狀腺腫的臨床誤診分析．吉林醫(yī)學 2002，6：359
第十四章 神經系統(tǒng)疾病
1. Garica JH, Ye ZR, Liu KF. Delayed neuronal death in experimental ischemic stroke. In:Ito U et al eds: Maturation Phenomenon in Cerebral Ischemia Ⅲ. Berlin: Springer-Verlag, 1999. 267-273.
2. 世界衛(wèi)生組織簡報（WHO Press).衛(wèi)生部國際合作司多邊處，中國預防醫(yī)學科學院科技情報中心聯(lián)合編譯，1999（17)：3-4
3. Loew J, LennoxG, Leigh PN. Disorders of movement and systemic degeneration.In: Graham DI, Lantos P, eds, Greenfields’sNeuropathology. 6th ed. London, New York: Oxford University Press, 1997.281-357
4.Garcia JH, Ye ZR. Epidemiology and pathology ofocclusive cerebrovascular disease. In: Crockard A, et al eds.Neurosurgery: The Scietific Basis of Clinical Practice, Oxford: Blackwell Science, 2000, 704-726
5.．Kleihues P, Cavenee WK（eds). Pathology and genetics, tumors of the nervous system. In:World Health Organization Classification of Tumor. Lyon:IARC Press, 2000
第十五章 傳染病
1.廖萬清, 吳紹熙主編. 真菌病研究進展. 第1版, 上海: 第二軍醫(yī)大學出版社, 1998,80-94
2. 劉清蒙. 基礎結核病學. 見劉清蒙，趙靜主編. 現(xiàn)代結核病學. 貴州：貴州科技出版社，1998.3-194
3..Pilheu JA. Tuberculosis2000: Problems and solutions. Int J Tuberc LungDis, 1998,2(9):696-703
4.Ksiazek TG, Rollin PE,Wiliams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus,virus antigen, and IgG and IgM antibody findings among EHF patients in kikwit, Democratic Republic of the Congo,1995. J Infet Dis, 1999,179 (Supp 1):S177-87
5.Samuelson J. Infectious disease. In: Cotran RS, Kumar V, Collins T, eds.Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders Company, 1999. 329-402.
6.Collier L, Balons A, Sussman M. Topley & Wilson’s Microbiology and MicrobialInfections Virology. 9th ed. London:Oxford University Press, Inc. 1998
7． Zhou D, Shen Y, Chalifoux L, et al. Mycobacterium bovis bacilleCalmette-Guerin enhances pathogenicity of simian immunodeficiency virusinfection and accelerates progression to AIDS in macaques: a role of persistentT cell activation in AIDS pathogenesis. J Immunol, 1999, 162: 2204-16.
8 陳菊梅主編. 現(xiàn)代傳染病學. 北京：人民軍醫(yī)出版社，1999
第十六章 寄生蟲病
1．陳興保，吳觀陵，孫新等主編. 現(xiàn)代寄生蟲病學. 北京：人民軍醫(yī)出版社2002
2．趙慰先，高淑芬主編. 實用血吸蟲病學. 北京：人民衛(wèi)生出版社 1996
3．馮振卿，俞小淙譯. 細粒棘球絳蟲的種內變異及對人體的致病性. 國外醫(yī)學寄生蟲病分冊，1998;25(2):64～66
4．宋曉彤，馮振卿譯. 泡球蚴病的免疫病理學.國外醫(yī)學寄生蟲病分冊，1998;25(6):270～272
5．趙慰先主編. 人體寄生蟲學. 第二版. 北京：人民衛(wèi)生出版社，1994, 122-140, 310-414, 521-538, 598-612
6．謝醒民、楊樹森主編. 臨床寄生蟲病學. 天津：天津科學技術出版社、天津教育出版社，1999, 1-285
7．曾憲芳主編. 寄生蟲學和寄生蟲學檢驗. 北京：人民衛(wèi)生出版社，1997，3-160
第十七章 診斷病理學概要
1. 劉彤華主編.診斷病理學，人民衛(wèi)生出版社，第二版，2006
第十八章 病理學常用新技術原理及應用
1．王伯沄 李玉松黃高昇 張遠強主編. 病理學技術. 北京：人民衛(wèi)生出版社2000
2． Harvey Lodish, ArnoldBerk, S.Lawrence Zipursky, Paul Matsudaira, David Baltimore, JamesE.Darnell. Molecular CellBiology W. H. FREEMAN ANDCOMPANY 4th ed 2000
3．汪謙主編. 現(xiàn)代醫(yī)學實驗方法. 第一版 北京：人民衛(wèi)生出版社， 1997
4．田東萍 吳名耀：組織芯片技術在腫瘤分子病理學研究中的應用，中國腫瘤2002，11（1)：52-53
5．蘇敏 田東萍 牛恕淼： AMeX包埋法簡介及在FISH中的應用. 中華病理學雜志1995；4：265
6．蘇敏 田東萍： 福爾馬林固定石蠟包埋標本細胞單離涂片F(xiàn)ISH技術. 西安醫(yī)科大學學報 1997；18（3)：399
